Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 8.
Article
Petzold, A;
Eikelenboom, MJ;
Gveric, D;
Keir, G;
Chapman, M;
Lazeron, RHC;
Cuzner, ML;
... Giovannoni, G; + view all
(2002)
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.
Brain
, 125
(7)
pp. 1462-1473.
10.1093/brain/awf165.
|
Petzold, A;
Gveric, D;
Groves, M;
Schmierer, K;
Grant, D;
Chapman, M;
Keir, G;
... Thompson, EJ; + view all
(2008)
Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology.
Experimental Neurology
, 213
(2)
326 - 335.
10.1016/j.expneurol.2008.06.008.
|
Petzold, A;
Keir, G;
Appleby, I;
(2007)
Marathon related death due to brainstem herniation in rehydration-related hyponatraemia: a case report.
Journal of Medical Case Reports
, 1
, Article 186. 10.1186/1752-1947-1-186.
|
Petzold, A;
Keir, G;
Green, AJE;
Giovannoni, G;
Thompson, EJ;
(2003)
A specific ELISA for measuring neurofilament heavy chain phosphoforms.
Journal of Immunological Methods
, 278
(1-2)
179 - 190.
10.1016/S0022-1759(03)00189-3.
|
Petzold, A;
Keir, G;
Sharpe, LT;
(2004)
Spectrophotometry for xanthochromia.
[Letter].
New England Journal of Medicine
, 351
(16)
1695 - 1696.
10.1056/NEJM200410143511627.
|
Petzold, A;
Keir, G;
Sharpe, TL;
(2005)
Why human color vision cannot reliably detect cerebrospinal fluid xanthochromia.
STROKE
, 36
(6)
1295 - 1297.
10.1161/01.STR.0000166344.75440.b9.
|
Petzold, A.;
Eikelenboom, M.J.;
Keir, G.;
Grant, D.;
Lazeron, R.H.C.;
Polman, C.H.;
Uitdehaag, B.M.J.;
... Giovannoni, G.; + view all
(2005)
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.
Journal of Neurology, Neurosurgery, and Psychiatry
, 76
(2)
pp. 206-211.
10.1136/jnnp.2004.043315.
|
Petzold, A.;
Eikelenboom, M.J.;
Keir, G.;
Polman, C.H.;
Uitdehaag, B.M.J.;
Thompson, E.J.;
Giovannoni, G.;
(2006)
The new Global Multiple Sclerosis Severity Score (MSSS) correlates with axonal but not glial biomarkers.
Multiple Sclerosis
, 12
(3)
pp. 325-328.
10.1191/135248505ms1277oa.
|